Michael F. Price’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-102,500
Closed -$3.35M 105
2018
Q2
$3.35M Sell
102,500
-175,000
-63% -$5.28M 0.4% 56
2018
Q1
$7.58M Sell
277,500
-6,700
-2% -$182K 0.9% 32
2017
Q4
$7.04M Hold
284,200
0.88% 33
2017
Q3
$8.29M Sell
284,200
-10,800
-4% -$298K 1.15% 26
2017
Q2
$8.18M Sell
295,000
-205,000
-41% -$5.44M 1.06% 28
2017
Q1
$12.4M Sell
500,000
-200,000
-29% -$4.86M 1.54% 22
2016
Q4
$15.1M Hold
700,000
1.84% 13
2016
Q3
$16.7M Sell
700,000
-200,000
-22% -$4.77M 2.21% 11
2016
Q2
$21M Sell
900,000
-840,000
-48% -$18.2M 2.79% 8
2016
Q1
$32.7M Sell
1,740,000
-240,000
-12% -$4.22M 4.6% 4
2015
Q4
$36.5M Hold
1,980,000
4.5% 3
2015
Q3
$32.5M Hold
1,980,000
4.86% 3
2015
Q2
$35M Hold
1,980,000
4.61% 4
2015
Q1
$35.1M Hold
1,980,000
4.65% 3
2014
Q4
$26.2M Sell
1,980,000
-20,000
-1% -$256K 3.2% 7
2014
Q3
$23.6M Hold
2,000,000
2.95% 9
2014
Q2
$25.5M Hold
2,000,000
3.13% 8
2014
Q1
$27M Hold
2,000,000
3.29% 5
2013
Q4
$24M Buy
2,000,000
+300,000
+18% +$3.54M 3.1% 5
2013
Q3
$20M Hold
1,700,000
2.65% 11
2013
Q2
$15.8M Buy
+1,700,000
New +$14.4M 2.11% 18

Other funds holding BSX

Michael F. Price's BSX Position: Q3 2018 in Review

Michael F. Price sold out of Boston Scientific (BSX) in Q3 2018, closing a stake of 102,500 shares — an estimated $3.35M sold.

Michael F. Price first reported a position in BSX in Q2 2013 and held it in 21 quarters. The position peaked at $36.5M in Q4 2015. 699 funds tracked by Wall St. Rank hold BSX as of Q3 2018.

  • Michael F. Price reported no remaining Boston Scientific position as of Q3 2018 after selling out during the quarter.
  • Michael F. Price sold 102,500 Boston Scientific shares in Q3 2018, an estimated $3.35M.
  • Michael F. Price first reported a position in Boston Scientific in Q2 2013 and held it in 21 quarters.
  • Michael F. Price's Boston Scientific position peaked at $36.5M in Q4 2015.
  • 699 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2018.

Based on Michael F. Price's 13F filing for Q3 2018, filed 14 Nov 2018.